Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Pancreatic Cancer × conteltinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 1 Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 2 toripalimab 1 penpulimab 1 fluzoparib 1 conteltinib 1 Paclitaxel 1 Nivolumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05580445 2023-11-22

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

Shouyao Holdings (Beijing) Co. LTD

Phase 1/2 Unknown

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡